Kyrodata
HubExplore
Explore
News
© 2026 Kyrodata. All rights reserved.
  • Terms
  • Privacy
  • Support
  • Status

3002 · Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micr

Catalog: 13,744 NCMs · 1,274 headings · 281 countries
Export PDFPro
Kyrodata · Panel
3002 · Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micr · Exports · 2016-01 → 2026-08 · monthly
Presets
›

Evolution · Volume & Average Price

›

Composition by SH6

Share of each SH6 within the selected SH4, in FOB. Top 12 shown.

›

Seasonality

Monthly index where 1.00 = yearly average. Shows which months the commodity is typically strong/weak based on export volume and FOB price for the current filter. · Average of 5 closed years (2021–2025)

›

Price Elasticity

How volume reacts to price
For every +1% in price, volume drops 0.87%.

Each +1% in price coincided with a 0.87% drop in volume (β=-0.87, R²=0.68, n=127) with strong historical fit.

β-0.87R²0.68observations 127

By partner country · top 5

Download CSVPro

Dashed line = aggregate β. Bars more transparent = weaker R² (less reliable fit).

›Show full table
Uruguay+0.030126inelastic · volume hardly sensitive
China-0.200.0355inelastic · volume hardly sensitive
United Kingdom-0.950.06110elastic · price affects volume
Colombia-0.990.67127elastic · price affects volume
Paraguay-1.170.54127very elastic · customer leaves on price
›

Rankings · Top Destinations/Origins + Opportunities

Top 10 destinations · who pays the most

ordered by average price (highest → lowest) · share ≥ 0.5%

Download CSVPro
Actions
Switzerland12.9M0.963.509K
China175.3M13.08693.235
Democratic Republic of the Congo10.1M0.76449.465
Nigeria17.5M1.31433.284
Italy9M0.67287.453
Germany55.8M4.16205.159
Hong Kong19.3M1.44185.358
United Kingdom117.6M8.77169.758
Uruguay83.1M6.20163.02
Guatemala9.1M0.68159.986

Partner positioning · price vs growth

top 30 partners · 12m window ending in 2026-08

›Show table ordered by FOB
Colombia14.8M10.30%6.719+34.48%
Russia13.3M9.26%5.074+30.07%
United Kingdom9.1M6.35%109.856-20.87%
China7.8M5.40%134.67-43.86%
Ecuador7.6M5.28%1.439+74.86%
Paraguay7.3M5.06%16.355-6.64%
Peru6.7M4.68%196.538+114.43%
Uruguay6.1M4.26%68.448-24.78%
Italy5.3M3.66%3.829K+1,033.33%
Vietnam5M3.49%1.694+24.49%
Guatemala4.5M3.16%719.067+9.63%
Switzerland4.5M3.15%348.33K+2,522.28%
Indonesia4.2M2.93%48.512+59.06%
Argentina3.9M2.72%22.079+83.63%
Costa Rica3.8M2.64%181.093+2,554.91%
Chile3.4M2.38%79.501+18.86%
Germany3M2.11%100.149+23.98%
Venezuela3M2.11%56.721+5.55%
Bolivia2.6M1.81%24.809-71.96%
Thailand2.5M1.73%70.253-10.11%
Mexico2.3M1.63%87.622+32.03%
India2.2M1.54%18.02+2.71%
United States2M1.40%11.422-39.80%
Netherlands2M1.39%84.38+6.33%
Philippines2M1.36%58.732+14.32%
Estonia1.5M1.03%109.896-19.57%
Honduras1.3M0.92%383.532+165.05%
Malaysia1.2M0.82%6.71+2,343.79%
Panama1.1M0.74%209.587+519.16%
France950.8K0.66%29.996-31.84%
Last years
Clear filters
SH43002Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micr